Kizuka et al. Nucl. Med. Biol, vol. 13, No. 5, pp. 551-555, 1986.* |
Beck-Sickinger, A. G. “Structure Characterization and Binding Sites of G-Protein-coupled Receptors” DDT, 1, 502-513, (1996). |
Hardman, J.G., et al. “The Pharmacological Basis of Therapeutics”, McGraw-Hill, New York, (1996), (Table of Contents). |
Hein, L. & Kobilka, B. K. “Adrenergic Receptor Signal Transduction and Regulation” Neuropharmacol, 34, 357-366, (1995). |
Kierstead, et al. “β1-Selective Adrenoceptor Antagonists. 1. Synthesis and β-Adrenergic Blocking Activity of a Series of Binary (Aryloxy)propanolamines.” Journal of Medicinal Chemistry, 26, 11, 1561-1569 (1983). |
Kizuka, et al. “β-Adreneoceptor Antagonist Activity of Bivalent Ligands. 1. Diamide Analogues of Practolol.”. Journal of Medicinal Chemistry, 30 722-726 (1987). |
Kurscheid, T. et al. “The cost implications of obesity of health care and society” Intl. J. of Obesity, 22 (suppl. 1):S3, (1998). |
Pitha, et al. “β-Adrenergic Antagonists with Multiple Pharmacophores: Persistent Blockade of Receptors”. Journal of Medicinal Chemistry, 26, 1 7-11 (1983). |
Pitha, et al. “Macromolecular β-Adrenergic Antagonists Discriminating Between Receptor and Antibody.” Proc. Nat'l, Acad. Sci. USA, 77, 2219-2223 (1980). |
Shuker, S.B., et al. “Discovering High-Affinity Ligands for Proteins: SAR by NMR,” Science, 274, 1531-1534 (1996). |
Shuker, S. B. et al. “Selective β 3 Receptor Antagonists and β Adrenergic Modulators for the Treatment of Obesity and NIDDM.” Abstracts of Papers, Part 1. 214th ACS National Meeting ACS: Las Vegas, NV, Sep. 7-11, 1997, Abstract MEDI-261. |
Siegel, M.G., et al. “The Use of High-Throughput Synthesis and Purification in the Preparation of a Directed Library of Adrenergic Agents.” Mol. Diversity. 3, 2, 113-116, (1998). |
Strosberg, A. D. “Structure, Function, and Regulation of Adrenergic Receptors” Protein Sci. 2, 1198-1209 (1993). |
Strosberg, A. D. & Pietri-Rouxel, F. “Function, and Regulation of β3 Adrenoreceptor” TiPS, 17, 373-381, (1996). |
Verlander, et al. “Biological Activity of Catecholamines Covanlenty Linked to Synthetic Polymers: Proof of Immobilized Drug Theory.” Proc. Nat'l Acad. Sci. USA, 73, 4, 1009-1013 (1976). |
Weiser, et al. “The Pharmacologic Approach to the Treatment of Obesity”. J. Clin. Pharmacol. 37:453, (1997). |
Portughese, Philip S. “The Role of Concepts in Structure—Activity Relationship Studies of Opioid Ligands.” J. Med. Chem. 35(11): 1927-1937 (1992). |
Zeng, L., et al. “Automated analytical/preparative high-performance liquid chromatography-mass spectrometry system for the rapid characterization and purification of compound libraries.” J. Chrom. A., 794: 3-13 (1998). |